EichorEICHOR
Location: Nagakute Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Nagakute

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Aichi Medical University Hospital · Boehringer Ingelheim · NCT06531824Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
NA · Aichi Medical University Hospital · Cosomil, Inc. · NCT07605819An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number: 3920062 · Sanofi · NCT07184931Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase 3 · Aichi Medical University Hospital · Juntendo University · NCT05392764Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension
Phase 3 · JPN006 · Insmed Incorporated · NCT07179380Special Drug Use-results Surveillance of Tafinlar/Mekinist
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06262919A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone
Phase 3 · Aichi Medial University Hospital · Regeneron Pharmaceuticals · NCT05730036An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With
Phase N/A · Aichi Medical University Hospital /ID# 261871 · AbbVie · NCT06023030A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Phase 2/Phase 3 · Aichi Medical University Hospital · Takeda · NCT05816382A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Ster
Phase 3 · Ep0162 20243 · UCB Biopharma SRL · NCT05077904Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can
Phase 3 · Aichi Medical University Hospital · Ferring Pharmaceuticals · NCT06510374A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Phase 2/Phase 3 · Aichi Medical University Hospital · Janssen Research & Development, LLC · NCT07196722Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ul
Phase N/A · Aichi Medical University Hospital /ID# 278155 · AbbVie · NCT07136116A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Phase 3 · Aichi Medical University Hospital /ID# 281613 · AbbVie · NCT07071519A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Di
Phase 3 · Aichi Medical University Hospital ( Site 3429) · Merck Sharp & Dohme LLC · NCT06430801
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.